Published in J Res Med Sci on October 01, 2011
Serum resistin levels may be new prognostic factor of crimean-congo hemorrhagic fever. Int J Clin Exp Med (2014) 0.78
Association of cardiac rehabilitation with improvement in high sensitive C-reactive protein post-myocardial infarction. Iran Red Crescent Med J (2012) 0.75
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85
Use and abuse of HOMA modeling. Diabetes Care (2004) 16.97
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23
The hormone resistin links obesity to diabetes. Nature (2001) 15.49
C-reactive protein: a critical update. J Clin Invest (2003) 11.77
Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA (2007) 7.79
Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA (2003) 7.35
FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J (2000) 3.81
Homocysteine metabolism. Annu Rev Nutr (1999) 3.75
C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med (2009) 3.50
Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out. Circulation (2006) 3.35
High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey. Arch Intern Med (2005) 2.70
Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes (2001) 2.43
Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab (2003) 2.25
Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia (2005) 2.23
Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus. Ann Saudi Med (2005) 2.21
A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem (2001) 2.09
Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1997) 1.34
Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol (2007) 1.27
High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes (2004) 1.24
Smoking is independently associated with high plasma insulin levels in nondiabetic men. Diabetes Care (1996) 1.10
Serum uric acid predicts progression of subclinical coronary atherosclerosis in individuals without renal disease. Diabetes Care (2010) 1.10
Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity. Endocr Regul (2010) 1.05
Relationships of cigarette smoking and alcohol consumption to metabolic syndrome in Japanese men. J Epidemiol (2010) 1.04
Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol (2010) 1.03
Circulating levels of resistin and risk of type 2 diabetes in men and women: results from two prospective cohorts. Diabetes Care (2008) 1.01
Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials. J Inherit Metab Dis (2010) 0.98
Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity? Diabetes Obes Metab (2004) 0.98
Smoking cessation increases serum adiponectin levels in an apparently healthy Greek population. Atherosclerosis (2009) 0.97
Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA. Am J Physiol Endocrinol Metab (2002) 0.94
Uric acid in heart disease: a new C-reactive protein? Curr Opin Rheumatol (2011) 0.93
Age, homocysteine, and oxidative stress: relation to hypertension and type 2 diabetes mellitus. J Am Coll Nutr (2010) 0.91
Linking observational and genetic approaches to determine the role of C-reactive protein in heart disease risk. Eur Heart J (2006) 0.91
Evidence for the involvement of resistin in inflammation and cardiovascular disease. Curr Diabetes Rev (2005) 0.90
Visfatin, resistin, hsCRP and insulin resistance in relation to abdominal obesity in women with rheumatoid arthritis. Clin Exp Rheumatol (2010) 0.87
Predictive value of serum uric acid on cardiovascular disease and all-cause mortality in urban Chinese patients. Chin Med J (Engl) (2010) 0.86
Effect of smoking habit on circulating adipokines in diabetic and non-diabetic subjects. Ann Nutr Metab (2008) 0.86
Homocysteine and markers of inflammation in acute coronary syndrome. Exp Clin Cardiol (2010) 0.84
Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: relationship to metabolic parameters and diabetic complications. Nutr Metab Cardiovasc Dis (2002) 0.83
Passive smoking in never-smokers is associated with increased plasma homocysteine levels. Int Heart J (2010) 0.82
Relation of resistin levels with cardiovascular risk factors, insulin resistance and inflammation in naïve diabetes obese patients. Diabetes Res Clin Pract (2010) 0.82
[Adipokines: adiponectin, leptin, resistin and coronary heart disease risk]. Przegl Lek (2005) 0.81
Preservation of cardiac contractility after long-term therapy with oxypurinol in post-ischemic heart failure in mice. Eur J Pharmacol (2009) 0.81
Altered levels of adipocytokines in type 2 diabetic cigarette smokers. Diabetes Res Clin Pract (2008) 0.80
An increase in serum uric acid concentrations is associated with an increase in the Framingham risk score in Korean adults. Clin Chem Lab Med (2011) 0.79
Osteopontin levels are associated with cholesterol synthesis markers in mildly hypercholesterolaemic patients. Acta Cardiol (2007) 0.78
The plasma homocysteine concentrations and prior myocardial infarction. Rom J Intern Med (2010) 0.77
Plasma soluble intercellular adhesion molecule 1 levels are increased in type 2 diabetic patients with nephropathy. Horm Res (2002) 0.86
Homocysteine and fibrinogen changes with L-thyroxine in subclinical hypothyroid patients. J Korean Med Sci (2007) 0.83
Evaluation of the JAK2-V617F gene mutation in Turkish patients with essential thrombocythemia and polycythemia vera. Mol Biol Rep (2012) 0.78
Relation of resistın wıth obesity and some cardiovascular risk factors in hypertensive women. J Res Med Sci (2012) 0.77
The relation of obesity with serum resistin levels in smoker and nonsmokers. J Res Med Sci (2012) 0.75
Relation of obesity with serum 25 hydroxy vitamin D3 levels in type 2 diabetic patients. J Res Med Sci (2012) 0.75
The effect of ursodeoxycholic acid treatment on epidermal growth factor in patients with bile reflux gastritis. Turk J Gastroenterol (2002) 0.75